Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn’s disease: a multicentre retrospective study
BackgroundPerianal fistulizing Crohn’s disease (pfCD) is a refractory complication of Crohn’s disease (CD) with limited therapeutic options, particularly for patients failing anti-tumor necrosis factor agents. Ustekinumab (UST) shows promise in pfCD, but long-term outcomes and predictive factors rem...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2026-07-01
|
| Seri Bilgileri: | Frontiers in Medicine |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1839761/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|